| (R,S) - Oxybutynin Hydrochloride |
| (R)-|A-Phenylcyclohexaneglycolic Acid 4-(Diethylamino)-2-butynyl Ester, Hydrochloride |
| (R)-OXYBUTYNIN HYDROCHLORIDE |
| (S)-|A-Phenylcyclohexaneglycolic Acid 4-(Diethylamino)-2-butynyl Ester, Hydrochloride |
| (s)-oxybutynin chloride |
| 1508-65-2 |
| 2-cyclohexyl-2-hydroxy-2-phenylacetic acid 4-(diethylamino)but-2-ynyl ester hydrochloride |
| 4-(Diethylamino)-2-butynyl (+-)-alpha-phenylcyclohexaneglycolate hydrochloride |
| 4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolate hydrochloride |
| 4-(diethylamino)but-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate hydrochloride |
| 4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenyl-acetate hydrochloride |
| 4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate hydrochloride |
| 4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate, chloride |
| 4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate;hydrochloride |
| 4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-oxidanyl-2-phenyl-ethanoate hydrochloride |
| 4-(Diethylamino)but-2-ynyl cyclohexylphenylglycolate hydrochloride |
| 4-Diethylamino-2-butynyl phenyl(cyclohexyl)glycolate hydrochloride |
| 5633-20-5 (Parent) |
| A809082 |
| AC1L3M7P |
| AK142874 |
| AKOS015895349 |
| alpha-Phenylcyclohexaneglycolic acid 4-(diethylamino)-2-butynyl ester hydrochloride |
| AN-49346 |
| API0003718 |
| Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester hydrochloride |
| Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester hydrochloride, (+-)- |
| BG0595 |
| C-21602 |
| C22H31NO3.HCl |
| C22H32ClNO3 |
| CAS-1508-65-2 |
| CCG-213420 |
| CHEBI:7857 |
| CHEMBL1133 |
| CPD000058490 |
| CS-2256 |
| CTK8G2229 |
| Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester, hydrochloride |
| D00722 |
| D05KZK |
| D0R1DH |
| Ditropan (TN) |
| Ditropan Xl |
| DL-06003 |
| Dridase |
| DSSTox_CID_25356 |
| DSSTox_GSID_45356 |
| DSSTox_RID_80822 |
| DTXSID3045356 |
| EINECS 216-139-7 |
| EU-0100923 |
| FT-0082889 |
| FT-0603563 |
| Gelnique (TN) |
| H33O205 |
| H815 |
| HMS1568J16 |
| HOB-294 |
| HY-B0267A |
| I06-0708 |
| J-008750 |
| J10411 |
| Jsp002882 |
| KS-00000ZDA |
| KS-1377 |
| LP00923 |
| LP052649 |
| LS-56862 |
| MCULE-5193326065 |
| MFCD00072150 |
| MJ 4309-1 |
| MJ-4309-1 |
| MLS000069688 |
| MLS001148211 |
| MLS002222232 |
| MolPort-003-666-668 |
| NC00580 |
| NCGC00016583-01 |
| NCGC00094234-01 |
| NCGC00094234-02 |
| NCGC00261608-01 |
| NSC-759108 |
| NSC759108 |
| O 2881 |
| Opera_ID_1330 |
| OR009708 |
| OR206939 |
| Oxibutinina hydrochloride |
| Oxybutynin (chloride) |
| Oxybutynin chloride |
| Oxybutynin chloride (USP) |
| Oxybutynin chloride [USAN:USP] |
| Oxybutynin chloride [USAN] |
| Oxybutynin chloride, >=98% (TLC), powder |
| Oxybutynin chloride, meets EP, USP testing specifications |
| Oxybutynin chloride, United States Pharmacopeia (USP) Reference Standard |
| Oxybutynin HCl |
| Oxybutynin hydrochloride |
| Oxybutynin hydrochloride (JAN) |
| Oxybutynin hydrochloride (transdermal patch, overactive bladder) |
| Oxybutynin hydrochloride (transdermal patch, overactive bladder), Hisamitsu |
| Oxybutynin hydrochloride, European Pharmacopoeia (EP) Reference Standard |
| Oxybutyninhydrochloride |
| Pharmakon1600-01505399 |
| Prestwick_621 |
| REGID_for_CID_91505 |
| s3117 |
| SAM002564226 |
| SC-18892 |
| SCHEMBL25751 |
| SMR000058490 |
| SMT-D002 |
| SR-01000000184 |
| SR-01000000184-2 |
| ST24048864 |
| ST51015085 |
| SWIJYDAEGSIQPZ-UHFFFAOYSA-N |
| Tox21_110507 |
| Tox21_500923 |
| Tropax |
| VA11467 |
